Researchers at Wenzhou Medical University reported the synthesis and preclinical evaluation of a novel series of betulin-succinate derivatives developed as potential anticancer agents. Betulin is a naturally occurring triterpene that shows significant potential as a lead compound for the development of novel antitumor agents, owing to its selective cytotoxicity against cancer cells and low toxicity toward normal cells.